TW200835700A - Polymerization inhibitor compositions, their preparation, and their use - Google Patents
Polymerization inhibitor compositions, their preparation, and their use Download PDFInfo
- Publication number
- TW200835700A TW200835700A TW96141963A TW96141963A TW200835700A TW 200835700 A TW200835700 A TW 200835700A TW 96141963 A TW96141963 A TW 96141963A TW 96141963 A TW96141963 A TW 96141963A TW 200835700 A TW200835700 A TW 200835700A
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- phenylhydroxylamine
- nitroso
- aluminum salt
- ginseng
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/38—Polymerisation using regulators, e.g. chain terminating agents, e.g. telomerisation
- C08F2/40—Polymerisation using regulators, e.g. chain terminating agents, e.g. telomerisation using retarding agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/38—Polymerisation using regulators, e.g. chain terminating agents, e.g. telomerisation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Polymerisation Methods In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
200835700 九、發明說明: 【發明所屬之技術領域】 本發明關於包括参(N-亞硝基-N-苯基羥基胺)鋁鹽之 新穎安定液體聚合抑制劑組成物,形成此組成物之方法, 及此組成物在光可硬化調配物之用途。 【先前技術】 参(N-亞硝基-N-苯基羥基胺)鋁鹽 CAS No. 1 5 3 0 5 - 0 7 - 4爲一種用於光可硬化調配物(亦稱爲輻射可硬 化調配物)非常有效之聚合抑制劑。此化合物係得自 Albemarle Corporation 之 FIRSTCURE® NPAL 聚合抑制劑 。参(N-亞硝基-N-苯基羥基胺)鋁鹽本身爲凝集固態。爲 了增強其作爲聚合抑制劑之用途,希望提供液體形式之化 合物。 迄今参(N-亞硝基-N_苯基羥基胺)鋁鹽已以具2_苯 氧基乙醇丙烯酸酯之液體聚合抑制劑摻合物銷售。然而不 巧地,此摻合物具有強烈之異味。因此需要一種提供参( N-亞硝基-N-苯基羥基胺)鋁鹽之安定溶液的方式,其安定 地用於形成光可硬化調配物而不招致強烈之異味。其特別 希望不論如何達成這些性質亦提供具有良好儲存安定性, 抑制其中使用此摻合物之光可硬化調配物的早熟聚合爲高 效率,及不負面地影響硬化光可硬化調配物而形成之硬化 產物的性質之透明溶液形式的安定摻合物。 【發明內容】 本發明提供具大部分(若非全部)以上屬性之液體聚 200835700 合抑制劑組成物。換言之,此組成物極適合在形成光可硬 化調配物中作爲添加劑。令人驚奇地,這些組成物可含約 10重量%或更多之参(亞硝基-N-苯基羥基胺)鋁鹽。這 些液體聚合抑制劑組成物係由包括参(N-亞硝基-N-苯基羥 基肢)銘鹽及以下之成分組成: a) 2-羥基-2-甲基苯丙酮、2-羥基-4,-(2-羥基乙氧基)-2-甲基苯丙酮、α,α-二乙氧基苯乙酮、或1-苯甲醯基環己 醇、或其任二或更多種之組合;或 Φ b)二苯基酮、至少一種其中具有苯甲醯基苯基之酯、或至 少一種其中具有苯甲醯基苯基之丙烯酸酯、或其任二或 更多種之組合;或 c) a)與b)兩者, 其條件爲如果a)爲1 -苯甲醯基環己醇,則至少一種得自b) 之成分亦存在於該組成物中。 如上所述,本發明之聚合抑制劑組成物爲液體。在a) 爲1 -苯甲醯基環己醇時,得自b)之成分亦存在於組成物中 ^ 而使組成物爲液體。關於此點參見美國專利第4,5 63,43 8 號。 本發明亦提供一種製造液體聚合抑制劑組成物之方法 ,此方法包括將参(N -亞硝基-N -苯基羥基胺)鋁鹽及以下 混合在一起: a) 2-羥基-2-甲基苯丙酮、2-羥基-4,-(2-羥基乙氧基)-2-甲基苯丙酮、α,α-二乙氧基苯乙酮、或1-苯甲醯基環己 醇、或其任二或更多種之組合;或 -6- 200835700 b) 二苯基酮、至少一種其中具有苯甲醯基苯基之酯、或至 少一種其中具有苯甲醯基苯基之丙烯酸酯、或其任二或 更多種之組合;或 c) a)與b)兩者, 其條件爲如果a)爲1-苯甲醯基環己醇,則至少一種得自b) 之成分亦存在於該組成物中而形成液體組成物。相較於在 相冋儲存條件下儲存純参(N -亞硝基-N -本基經基胺)銘鹽 ,儲存此液體組成物造成溶液經較長時間仍維持無固體。 • 本發明亦提供含聚合抑制劑之光可硬化調配物的製備 。此調配物包括至少一種光可硬化單體、寡聚物及/或聚合 物,其中改良爲調配物中之聚合抑制劑爲一種由包括参( N-亞硝基-N-苯基羥基胺)鋁鹽及以下之成分形成之液體: a) 2-羥基-2-甲基苯丙酮、2-羥基-4,-(2-羥基乙氧基)-2-甲基苯丙酮、α,α-二乙氧基苯乙酮、或1-苯甲醯基環己 醇、或其任二或更多種之組合;或 b) 一本基酮、至少一種其中具有苯甲醯基苯基之酯、或至 ^ 少一種其中具有苯甲醯基苯基之丙烯酸酯、或其任二或 更多種之組合;或 c) a)與b)兩者, 其條件爲如果a)爲1-苯甲醯基環己醇,則至少一種得自b) 之成分亦存在於該組成物中。 本#明之其他具體實施例及特點由以下說明及所附申 請專利範圍進一步明顯可知。 200835700 【實施方式】 在全部本文件中,除非另有指示,所有比例及百分比 均爲重量比。 二苯基酮在成爲取代基部分時稱爲苯甲醯基苯基。亦 應了解,除非另有所述,在全部本文件中使用之名詞「苯 甲醯基苯基」包括經取代及未取代苯甲醯基苯基。在將含 經取代苯甲醯基苯基之化合物用於形成液體聚合抑制劑組 成物時’苯甲醯基苯基上之取代基可爲不妨礙液體聚合抑 制劑組成物形成之任何取代基。 本發明之一個特點爲可將相當大量之参(N-亞硝基-N-苯基經基胺)鋁鹽以液體形式用於聚合抑制劑組成物。按 組成物之總重量計爲至少約a. 1 %,經常爲約5 %至約1 〇 % ,而且至多約12%之参(Ν_亞硝基-Ν-苯基羥基胺)鋁鹽已 成功地包括於本發明之液體聚合抑制劑組成物中。 1)聚合抑制劑組成物 如以上可知,本發明可得多種聚合抑制劑組成物。一 種型式之新穎聚合抑制劑組成物爲由包括参(Ν-亞硝基-Ν-苯基羥基胺)鋁鹽及2 -羥基-2-甲基苯丙酮、2 -羥基-4’-( 2 -經基乙氧基)-2-甲基苯丙醒、α,α -二乙氧基苯乙酬、或 其任二或更多種之組合的成分形成之液體形式。用於混合 参(Ν-亞硝基-Ν-苯基羥基胺)鋁鹽之較佳成分爲2-羥基-2-甲基苯丙酮。 另一型本發明可得之新穎聚合抑制劑組成物爲由包括 参(Ν-亞硝基苯基羥基胺)鋁鹽及二苯基酮、至少一種 其中具有苯甲醯基苯基之酯、或至少一種其中具有苯甲醯 200835700 基苯基之丙烯酸酯、或其任二或更多種之組合形成之液體 形式。用於混合参(N-亞硝基-N-苯基羥基胺)鋁鹽之較佳 成分爲二苯基酮及至少一種其中具有苯甲醯基苯基之酯; 更佳爲二苯基酮。 用於形成本發明組成物之苯甲醯基苯基酯可由以下結 構表示:200835700 IX. DESCRIPTION OF THE INVENTION: TECHNICAL FIELD OF THE INVENTION The present invention relates to a novel stable liquid polymerization inhibitor composition comprising a ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt, and a method of forming the same And the use of the composition in a photohardenable formulation. [Prior Art] Sodium (N-nitroso-N-phenylhydroxylamine) aluminum salt CAS No. 1 5 3 0 5 - 0 7 - 4 is a photohardenable formulation (also known as radiation hardenable) Formulations) very effective polymerization inhibitors. This compound was obtained from FIRSTCURE® NPAL polymerization inhibitor from Albemarle Corporation. The ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt itself is an agglomerated solid. In order to enhance its use as a polymerization inhibitor, it is desirable to provide a compound in liquid form. To date, the (N-nitroso-N-phenylhydroxylamine) aluminum salt has been marketed as a liquid polymerization inhibitor blend having 2-phenoxyethanol acrylate. Unfortunately, this blend has a strong off-taste. There is therefore a need for a way to provide a stability solution of the ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt which is used to form a photohardenable formulation without incurring a strong off-taste. It is particularly desirable to provide these properties regardless of how they provide good storage stability, inhibit premature polymerization of the photohardenable formulation in which the blend is used to high efficiency, and not adversely affect the hardened photohardenable formulation. A stable blend in the form of a clear solution of the nature of the hardened product. SUMMARY OF THE INVENTION The present invention provides a liquid poly 200835700 combined inhibitor composition having most, if not all, of the above attributes. In other words, this composition is highly suitable as an additive in the formation of photohardenable formulations. Surprisingly, these compositions may contain about 10% by weight or more of the ginseng (nitroso-N-phenylhydroxylamine) aluminum salt. These liquid polymerization inhibitor compositions are composed of the ginseng (N-nitroso-N-phenylhydroxyl) salt and the following components: a) 2-hydroxy-2-methylpropiophenone, 2-hydroxy- 4,-(2-hydroxyethoxy)-2-methylpropiophenone, α,α-diethoxyacetophenone, or 1-benzylidenecyclohexanol, or any two or more thereof a combination; or Φ b) diphenyl ketone, at least one ester having a benzhydryl phenyl group therein, or at least one acrylate having a benzhydryl phenyl group therein, or a combination of two or more thereof Or c) both a) and b), provided that if a) is 1-bensylcyclohexanol, at least one component from b) is also present in the composition. As described above, the polymerization inhibitor composition of the present invention is a liquid. When a) is 1-bensylcyclohexanol, the component derived from b) is also present in the composition ^ to make the composition liquid. See U.S. Patent No. 4,5 63,43 8 for this. The invention also provides a process for the manufacture of a liquid polymerization inhibitor composition which comprises mixing a ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt and the following: a) 2-hydroxy-2- Methylpropiophenone, 2-hydroxy-4,-(2-hydroxyethoxy)-2-methylpropiophenone, α,α-diethoxyacetophenone, or 1-benzylidenecyclohexanol Or a combination of two or more thereof; or -6- 200835700 b) diphenyl ketone, at least one ester having a benzylidene phenyl group therein, or at least one acrylic acid having a benzylidene phenyl group therein An ester, or a combination of two or more thereof; or c) both a) and b), provided that if a) is 1-benzylidenecyclohexanol, at least one component derived from b) It is also present in the composition to form a liquid composition. The storage of this liquid composition caused the solution to remain solid-free over a longer period of time than the storage of pure ginseng (N-nitroso-N-benzamide) under salt storage conditions. • The present invention also provides the preparation of a photohardenable formulation containing a polymerization inhibitor. The formulation comprises at least one photohardenable monomer, oligomer and/or polymer, wherein the polymerization inhibitor is modified to include a ginseng (N-nitroso-N-phenylhydroxylamine) Aluminium salt and a liquid formed by the following components: a) 2-hydroxy-2-methylpropiophenone, 2-hydroxy-4,-(2-hydroxyethoxy)-2-methylpropiophenone, α,α- Diethoxyacetophenone, or 1-benzylidenecyclohexanol, or a combination of any two or more thereof; or b) a ketone, at least one ester having a benzhydrylphenyl group therein Or at least one acrylate having a benzhydrylphenyl group, or a combination of two or more thereof; or c) both a) and b), provided that a) is 1-benzene For mercaptocyclohexanol, at least one component derived from b) is also present in the composition. Other specific embodiments and features of the present invention will be apparent from the following description and the appended claims. 200835700 [Embodiment] Throughout this document, all ratios and percentages are by weight unless otherwise indicated. Diphenyl ketone is referred to as a benzyl phenyl phenyl group when it becomes a substituent moiety. It should also be understood that the term "benzimidyl" as used throughout this document, unless otherwise indicated, includes substituted and unsubstituted benzhydrylphenyl. When a compound containing a substituted benzhydrylphenyl group is used to form a liquid polymerization inhibitor composition, the substituent on the benzhydrylphenyl group may be any substituent which does not hinder the formation of the liquid polymerization inhibitor composition. A feature of the present invention is that a relatively large amount of the ginseng (N-nitroso-N-phenylcarbylamine) aluminum salt can be used in a liquid form for the polymerization inhibitor composition. At least about 1%, often from about 5% to about 1% by weight, based on the total weight of the composition, and up to about 12% of the ginseng (nitroso-indolyl-phenylhydroxylamine) aluminum salt Successfully included in the liquid polymerization inhibitor composition of the present invention. 1) Polymerization inhibitor composition As apparent from the above, various polymerization inhibitor compositions are available in the present invention. One type of novel polymerization inhibitor composition is composed of ruthenium (nitroso-nitro-p-phenylhydroxylamine) aluminum salt and 2-hydroxy-2-methylpropiophenone, 2-hydroxy-4'-(2 a liquid form formed by the component of ethoxylated)-2-methylphenyl acetonide, α,α-diethoxy phenyl hexahydrate, or a combination of any two or more thereof. A preferred component for mixing the aluminum salt of ginseng (nitroso-quinone-phenylhydroxylamine) is 2-hydroxy-2-methylpropiophenone. Another novel polymerization inhibitor composition obtainable by the present invention is an ester comprising stilbene (nitrosophenylphenylhydroxylamine) aluminum salt and diphenyl ketone, at least one ester having benzhydryl phenyl group therein, Or a liquid form formed by at least one acrylate having a benzamidine 200835700-phenyl group, or a combination of two or more thereof. A preferred component for mixing the ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt is diphenyl ketone and at least one ester having a benzhydryl phenyl group; more preferably diphenyl ketone . The benzepidine phenyl ester used to form the composition of the present invention can be represented by the following structure:
〇 〇〇 〇
佳爲R含至多約12個原子;更佳爲r具有約i至約6個Preferably, R contains up to about 12 atoms; more preferably r has from about i to about 6
原子。應了解,這些結構代表不視爲限制含苯甲醯基苯基 酯。其可存在超過一個酯基,而且此酯基可在相同環或分 別之環上。取代基可存在於苯甲醯基苯基之一或兩個環上 。合適之取代基包括烷基(較佳爲Ci至C6 )、烷氧基( 較佳爲具有至多約1 2個碳原子)、醚、酯、胺基、及/或 酸胺基_。本甲酸基苯基之取代基的實例包括但不限於甲 基、乙基、正丙基、異丙基、正丁基、第二丁基、第三丁 基、戊基、環戊基、己基、環己基、庚基、辛基、壬基、 羥基、甲氧基、乙氧基、三氟甲基、胺基、甲胺基、二乙 胺基、二丁胺基、硝基、與氟基。R,可爲但不限於烷基、 醚、胺基、或醯胺基。較佳爲R,含至多約12個原子;更 佳爲V具有約1至約6個原子。合適之R,包括甲基、乙基 、正丙基、異丙基、正丁基、第二丁基、第三丁基 '戊基 200835700 、環戊基、己基、環己基、庚基、辛基、壬基、三氟甲基 、胺基、甲胺基、二乙胺基、二丁胺基、氟等。 適合用於本發明之其中具有苯甲醯基苯基之酯包括但 不限於鄰苯甲醯基苯甲酸甲酯、間苯甲醯基苯甲酸乙酯、 對苯甲醯基苯甲酸正丙酯、2-(3-苯甲醯基苯基)丙酸異 丙酯、2-(對氯苯甲醯基)苯基丙酸正丁酯、(3 -苯甲醯 基-2-甲氧基苯基)乙酸第二丁酯、(2-胺基-3-苯甲醯基苯 基)乙酸第三丁酯、4-苯甲醯基-α-甲基苯乙酸戊酯、2-( # 間苯甲醯基苯氧基)乙酸環戊酯、2-胺基-(4’-氯苯甲醯基 )苯基乙酸己酯、4-(2-甲基- 3-(4-氯苯甲醯基)苯基) 丁酸環己酯、2_胺基-3- ( 4-溴苯甲醯基)苯乙酸庚酯、5-(2,4-二氯苯甲醯基)-2-羥基- 5-(4-氟苯甲醯基>-2-羥基 -α-甲基苯乙酸壬酯、2-(4-甲基苯甲醯基)苯甲酸甲酯、 4-甲基二苯基酮-2-羧酸乙酯、2- (4-乙基苯甲醯基)苯甲 酸正丙酯、4-乙基二苯基酮-2-羧酸乙酯、4,4’-二甲氧基二 苯基酮-2,2’-二羧酸甲酯、二苯基酮-4,4’-二羧酸第二丁酯 ^ 、二苯基酮-2,2’,4-三羧酸第三丁酯、二苯基酮-3,3’,4,4’- 四羧酸正丁酯、二苯基酮- 2,2’,5,5’-四羧酸戊酯、鄰苯甲醯 基苯甲酸己酯、間苯甲醯基苯甲酸環戊酯、對苯甲醯基苯 甲酸環己酯、2 - ( 3,4 -二甲基苯甲醯基)苯甲酸庚酯、2 -(2-羥基-5-甲基苯甲醯基)苯甲酸辛酯、2- (2,3-二氟苯 甲醯基)苯甲酸壬酯、2-(4-氟-3-甲基苯甲醯基)苯甲酸 甲酯、2-(2,3,4,5,6-五甲基苯甲醯基)苯甲酸甲酯、2-( 4-羥基-3,5-二甲基苯甲醯基)苯甲酸乙酯、2- ( 2-胺基苯 -10- 200835700 甲醯基)苯甲酸異丙酯、2-(3,5 -貳(三氟甲基)苯甲酿基 )苯甲酸第三丁酯、2-[4-(二丁胺基)-2-羥基苯甲醯基] 苯甲酸甲酯、2_ ( 4_氟苯甲醯基)苯甲酸甲酯、八(扣經基 苯甲醯基)苯甲酸乙酯、2-(4 -甲基苯甲醯基)苯甲酸異 丙酯、2- ( 3-胺基苯甲醯基)苯甲酸第二丁酯、二乙 胺基-2-羥基苯甲醯基)苯甲酸甲酯、2-苯甲醯基-硝基苯 甲酸己酯、2 -苯甲醯基_3_硝基苯甲酸戊酯等。atom. It should be understood that these structures are not considered to limit the inclusion of benzhydryl phenyl ester. It may be present in more than one ester group and this ester group may be on the same ring or on separate rings. The substituent may be present on one or both of the benzhydrylphenyl groups. Suitable substituents include alkyl groups (preferably Ci to C6), alkoxy groups (preferably having up to about 12 carbon atoms), ethers, esters, amine groups, and/or acid amine groups. Examples of the substituent of the present formate phenyl include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, t-butyl, pentyl, cyclopentyl, hexyl , cyclohexyl, heptyl, octyl, decyl, hydroxy, methoxy, ethoxy, trifluoromethyl, amine, methylamino, diethylamino, dibutylamino, nitro, and fluorine base. R, which may be, but not limited to, an alkyl group, an ether group, an amine group, or a guanamine group. Preferably, R contains up to about 12 atoms; more preferably V has from about 1 to about 6 atoms. Suitable R, including methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, tert-butyl 'pentyl 200835700, cyclopentyl, hexyl, cyclohexyl, heptyl, octyl Base, fluorenyl, trifluoromethyl, amine, methylamino, diethylamino, dibutylamine, fluorine, and the like. Esters having benzhydrylphenyl groups suitable for use in the present invention include, but are not limited to, methyl phthalate, ethyl m-benzoyl benzoate, n-propyl p-benzoyl benzoate. , 2-(3-benzylidenylphenyl)propionic acid isopropyl ester, 2-(p-chlorobenzopyridyl)phenylpropionic acid n-butyl ester, (3-benzoyl-2-yloxy) Phenyl)acetic acid second butyl ester, (2-amino-3-benzhydrylphenyl)acetic acid tert-butyl ester, 4-benzylidene-α-methylphenylacetic acid amyl ester, 2-(# Cyclopropenylphenoxy)acetic acid cyclopentyl ester, 2-amino-(4'-chlorobenzylidene)phenylhexyl acetate, 4-(2-methyl-3-(4-chlorobenzene) Mercapto)phenyl)butyric acid cyclohexyl ester, 2-amino-3-(4-bromobenzylidene)p-butyl acetate, heptyl 5-(2,4-dichlorobenzylidene)-2 -hydroxy- 5-(4-fluorobenzhydryl)>-2-hydroxy-α-methylphenylacetate, methyl 2-(4-methylbenzimidyl)benzoate, 4-methyl Ethyl diphenyl ketone-2-carboxylate, n-propyl 2-(4-ethylbenzylidene)benzoate, ethyl 4-ethyldiphenyl ketone-2-carboxylate, 4,4' -Dimethoxydiphenyl ketone-2,2'-dicarboxylic acid methyl ester, diphenyl ketone-4 , 4'-dicarboxylic acid second butyl ester ^, diphenyl ketone-2,2',4-tricarboxylic acid tert-butyl ester, diphenyl ketone-3,3',4,4'-tetracarboxylic acid N-butyl acrylate, diphenyl ketone - 2,2',5,5'-tetracarboxylic acid amyl ester, phthalyl benzoyl benzoate, cyclopentyl m-benzoyl benzoate, p-phenylene Cyclohexyl benzoate, heptyl 2-(3,4-dimethylbenzylidene)benzoate, octyl 2-(2-hydroxy-5-methylbenzylidene)benzoate, 2 - (2,3-difluorobenzhydryl)benzoic acid oxime ester, methyl 2-(4-fluoro-3-methylbenzylidene)benzoate, 2-(2,3,4,5, Methyl 6-pentamethylbenzhydryl)benzoate, ethyl 2-(4-hydroxy-3,5-dimethylbenzimidyl)benzoate, 2-(2-aminophenyl-10- 200835700 Methyl isopropyl benzoate, 2-(3,5-indole (trifluoromethyl)benzyl)benzoic acid tert-butyl ester, 2-[4-(dibutylamino)-2 -hydroxybenzylidene] methyl benzoate, methyl 2-(4-fluorobenzhydryl)benzoate, ethyl octabenzoate, 2-(4-methylbenzene) Methyl benzoate isopropyl benzoate, 2-butyl 3-(3-aminobenzylidene) benzoate, Ethyl-2-hydroxybenzamide acyl amino) benzoate, 2-benzoyl-yl - nitrophenyl acid hexyl ester, 2 - nitro-benzoyl _3_ amyl group and the like.
較佳之苯甲醯基苯基酯僅具有一個酯基;亦較佳爲無 取代基之苯甲醯基苯基酯。更佳爲有或無取代基之苯甲醯 基本甲酸酯(亦已知爲二苯基酮竣酸酯)。仍更佳爲無取 代基之苯甲醯基苯甲酸酯(即鄰苯甲醯基苯甲酸酯、間苯 甲醯基苯甲酸酯與對苯甲醯基苯甲酸酯)。高度較佳之苯 甲醯基苯基酯爲鄰苯甲醯基苯甲酸甲酯。 用於形成本發明組成物之其中具有苯甲醯基苯基之丙 烯酸酯可由以下結構表示:Preferably, the benzhydryl phenyl ester has only one ester group; and is preferably an unsubstituted benzyl phenyl phenyl ester. More preferred are benzamidine basic orthoesters (also known as diphenyl ketone phthalate). Still more preferred is the benzylidene benzoate (i.e., o-benzimidyl benzoate, m-benzoyl benzoate, and p-benzoyl benzoate). A highly preferred benzhydrylphenyl ester is methyl orthobenzoylbenzoate. The acrylate having a benzamidine phenyl group for forming the composition of the present invention can be represented by the following structure:
其中R ”可爲但不限於氫、烷基、醚、酯、胺基、或醯胺基 。較佳爲R”含至多約12個原子;更佳爲R”具有約i至約 6個原子。應了解,此結構代表不視爲限制其中具有苯甲 醯基苯基之丙烯酸酯。取代基可存在於苯甲醯基苯基之— 或兩個環上。苯甲醯基苯基之合適取代基包括烷基(較佳 爲<^至(:6)、烷氧基(較佳爲具有至多約12個碳原子) -11- 200835700 、醚、酯、胺基、及/或醯胺基等。苯甲醯基苯基環上之取 代基的實例包括但不限於甲基、乙基、正丙基、異丙基、 正丁基、第二丁基、第三丁基、戊基、環戊基、己基、環 己基、庚基、辛基、壬基、羥基、甲氧基、乙氧基、三氟 甲基、胺基、甲胺基、二乙胺基、二丁胺基、硝基、與氟 基。R ”可爲但不限於烷基、醚、胺基、或醯胺基。較佳爲 R”含至多約12個原子;更佳爲R”具有約1至約6個原子 。合適之R”包括氫、甲基、乙基、正丙基、異丙基、正丁 II 基、第二丁基、第三丁基、戊基、環戊基、己基、環己基 、庚基、辛基、壬基、胺基、甲胺基、二乙胺基、二丁胺 基等。 . 其有數種方式將可作爲本發明組成物之成分的其中具 有苯甲醯基苯基之丙烯酸酯命名。例如在以上結構中環未 取代’則在R”爲氫時化合物可稱爲苯甲醯基苯基丙烯酸酯 或苯甲醯基苯基2-丙酸酯;類似地,在R”爲甲基時化合 物可稱爲苯甲醯基苯基丙烯酸甲酯或4-苯甲醯基苯基2-甲 •基-2 -丙酸酯。 適合用於本發明之其中具有苯甲醯基苯基之丙烯酸酯 包括鄰苯甲醯基苯基丙烯酸酯、間苯甲醯基苯基丙烯酸酯 、對苯甲醯基苯基丙烯酸酯、2-甲氧基-間苯甲醯基苯基丙 燦酸酯、鄰苯甲醯基苯基丙烯酸甲酯、間苯甲醯基苯基丙 _酸乙酯、對苯甲醯基苯基丙烯酸異丙酯、2-甲氧基-間苯 甲醯基苯基丙烯酸正丁酯、4-苯甲醯基-3-羥基苯基甲基丙 烯酸酯等。 -12- 200835700 較佳之其中具有苯甲醯基苯基之丙烯酸酯爲 之苯甲醯基苯基丙烯酸酯。更佳之丙烯酸酯爲其c 之未取代苯甲醯基苯基丙烯酸酯。 第三型之本發明新穎聚合抑制劑組成物爲由 N-亞硝基-N-苯基羥基胺)鋁鹽及c) ( a)2_羥基- 2-酮、2-羥基_4,-(2-羥基乙氧基)-2-甲基苯丙酮、 氧基苯乙酮、或1-苯甲醯基環己醇、或其任二或 組合’及b)二苯基酮、至少一種其中具有苯甲醯 酯 '或至少一種其中具有苯甲醯基苯基之丙烯酸 任二或更多種之組合)之成分形成之溶液形式。 参(N-亞硝基-N-苯基羥基胺)鋁鹽之成分的較佳 2-羥基-2-甲基苯丙酮與二苯基酮、2-羥基-2-甲基 鄰苯甲醯基苯甲酸甲酯、及1-苯甲醯基環己醇與 ;更佳爲2-羥基-2-甲基苯丙酮與二苯基酮。a)對 可爲任意,如0 · 1 ·· 9 9.9至9 9.9 : 0.1,其限制條件 液體。對於涉及1-苯甲醯基環己醇之組合,1-苯 己醇之量爲使得組成物爲液體,而且通常爲組合 約80%之範圍;更佳爲1-苯甲醯基環己醇爲組合 至約70%之範圍;甚至更佳爲約40%至約60%之 基環己醇。對於涉及至少一種其中具有苯甲酿基 及/或至少一種其中具有苯甲醯基苯基之丙烯酸 ,在酯或丙烯酸酯爲固體時,固體酯或丙烯酸酯 與b)組合之約80%或更少。a)對b)之較佳比例焉 至約8 0 : 2 0之軔圍,更佳爲a)對b)之較佳比例怎 無取代基 P ”爲氫 包栝参( 甲基苯丙 α,α-二乙 更多種之 基苯基之 酯、或其 用於混合 組合包括 苯丙酮與 二苯基酮 b)之比例 組成物爲 甲醯基環 之約5至 之約30% 1 -苯甲釀 苯基之酯 酯的組合 通常爲a) | 約 2 0 : 8 0 I 約 30:70 -13- 200835700 至約7 0 : 3 0之範圍。仍更佳爲a)對b)之比例爲約4 0 : 6 0至 約60:40之範圍。 本發明之液體聚合抑制劑組成物在常用有機溶劑與介 質中具有良好之溶解度,良好之安定性,及高度有效地抑 制可使用其之各種光可硬化調配物的早熟聚合。此外這些 摻合物之成分可分配以提供極少(若有)之異味。 本發明之液體聚合抑制劑組成物含按組成物之總重量 計爲至少約〇 . 1重量%,一般爲至少約1重量%,較佳爲至 # 少約5重量%,而且更佳爲至少約6重量%之参(Ν-亞硝基 -Ν-苯基羥基胺)鋁鹽。至多約8重量%、10重量%及12 重量%之量的参(Ν-亞硝基-Ν-苯基羥基胺)鋁鹽可存在於 本發明之液體組成物。摻合物之成分係分配使得其不超過 参(Ν-亞硝基-Ν-苯基羥基胺)鋁鹽在用於形成液體組成物 之特定成分中的室溫(例如2 3 °C )溶解度限制。然而在產 物外觀不爲重要因素之情形,組成物可甚至爲濃縮混濁液 • 参(N-亞硝基-N-苯基羥基胺)鋁鹽之製備在此技藝爲 已知的且敘述於例如美國專利第6,0 1 8,0 7 8號。例如参( N-亞硝基-N-苯基羥基胺)鋁鹽可藉由反應鋁鹽(如硫酸鋁 鹽)與N-亞硝基-N-苯基羥基胺銨鹽而製備,雖然亦可使 用其他金屬鹽’如鹵鹽、磷酸鹽、硝酸鹽、碳酸鹽、與有 機酸鹽。 爲了形成本發明之聚合抑制劑組成物,其使用典型混 合設備,如摻合槽或裝有合適攪動或攪拌裝置之容器,將 -14- 200835700 其成分以任何合適方式混合在一起。 額外成分可包括於本發明之液體聚合抑制劑組成物中 ,其限制條件爲此成分實際上不減損使用其之組成物的有 益屬性。可包括於本發明摻合物之額外成分的非限制實例 包括染料、丙烯酸酯及/或甲基丙烯酸酯單體及/或甲基丙 烯酸酯寡聚物、常用有機溶劑、氧化抑制劑、黏度修改劑 、塡料、光引發劑、及三級胺。此額外成分之指定非限制 實例包括丙酮、異丙醇、乙腈、蠟、聚合物粉末、N,N-二 • 乙基-4-胺基苯(DEAB)、氧化(2,4,6-三甲基苯甲醯基)二 苯基膦(TPO,Albemarle Corporation)、2-甲基-1-[4-(甲硫 基)苯基]-2-嗎啉基丙-1-酮(Irgacure® 907,Ciba Chemical Specialties)、氧化苯基戴(2,4,6 -三甲基苯甲酸基)膦 (Irgacure® 819,Ciba Chemical Specialties)、液體脂族胺增 效劑(FIRSTCURE® AS-5 胺,Albemarle Corporation )、 4-(二甲胺基)苯甲酸乙酯(ED AB)、4-(二甲胺基)苯甲 酸 2-乙基己酯(ODAB,Albemarle Corporation)、N -甲基 ^ -N,N-二乙醇胺、参(2,4-二第三丁基苯基)亞磷酸酯 (ETHAPH0S™ 3 6 8,A1 b e m ar 1 e C o r p o r at i ο η)、及 3 - ( 3,5-二第三丁基-4-羥基苯基)丙酸十八碳酯(ETHANOX® 376, Albemarle Corporation) 〇 在將額外成分用於形成本發明之聚合抑制劑組成物時 ,所得液體聚合抑制劑組成物應含至少約1 〇重量%之参( N-亞硝基-N-苯基羥基胺)鋁鹽與 a)2-羥基-2-甲基苯丙酮 、2-羥基_4’-(2-羥基乙氧基)-2-甲基苯丙酮、a,oc-二乙氧 -15- 200835700 基苯乙酮、或1-苯甲醯基環己醇、或其任二或更多種之組 合;或b)二苯基酮、至少一種其中具有苯甲醯基苯基之酯 、或至少一種其中具有苯甲醯基苯基之丙烯酸酯、或其任 二或更多種之組合;或c) a)與b)兩者的組合,其條件爲如 果a)爲1-苯甲醯基環己醇,則至少一種得自b)之成分亦存 在於該組成物中。Wherein R" can be, but is not limited to, hydrogen, alkyl, ether, ester, amine, or guanamine. Preferably, R" contains up to about 12 atoms; more preferably R" has from about i to about 6 atoms. It should be understood that this structure is not to be construed as limiting the acrylate having a benzhydrylphenyl group. The substituent may be present on the benzoylphenyl group or on both rings. Suitable for the benzhydrylphenyl group. Substituents include alkyl groups (preferably <^ to (:6), alkoxy groups (preferably having up to about 12 carbon atoms) -11-200835700, ethers, esters, amine groups, and/or guanamines Examples of the substituents on the benzhydrylphenyl ring include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, t-butyl, pentyl , cyclopentyl, hexyl, cyclohexyl, heptyl, octyl, decyl, hydroxy, methoxy, ethoxy, trifluoromethyl, amine, methylamino, diethylamino, dibutylamino And a nitro group, and a fluoro group. R" may be, but not limited to, an alkyl group, an ether group, an amine group, or a guanamine group. Preferably, R" contains up to about 12 atoms; more preferably R" has from about 1 to about 6 atoms. Suitably R" includes hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl II, t-butyl, tert-butyl, pentyl, cyclopentyl, hexyl, cyclohexyl, heptyl , octyl, decyl, amine, methylamino, diethylamino, dibutylamine, etc. There are several ways in which acrylic acid having a benzhydrylphenyl group can be used as a component of the composition of the present invention. The ester nomenclature. For example, in the above structure, the ring is unsubstituted, and when R is hydrogen, the compound may be referred to as benzhydrylphenyl acrylate or benzepidine phenyl 2-propionate; similarly, at R" The methyl group compound may be referred to as methyl benzhydryl phenyl acrylate or 4-benzylidene phenyl 2-methyl -2-propionate. Suitable for use in the present invention having benzhydryl benzene Acrylates include o-benzimidyl phenyl acrylate, m-benzoyl phenyl acrylate, p-benzoyl phenyl acrylate, 2-methoxy-m-benzoyl phenyl propyl acrylate Acid ester, methyl phthalyl phenyl acrylate, m-benzyl phenyl propyl acrylate, isopropyl p-benzoyl phenyl acrylate, 2-methoxy- N-butyl benzhydryl phenyl acrylate, 4-benzylidene-3-hydroxyphenyl methacrylate, etc. -12- 200835700 Preferably, acrylate having a benzhydryl phenyl group is benzophenone Nonylphenyl acrylate. More preferably, the acrylate is an unsubstituted benzhydryl phenyl acrylate of c. The novel polymerization inhibitor composition of the present invention of the third type is N-nitroso-N-phenyl Hydroxylamine) aluminum salt and c) (a) 2-hydroxy-2-one, 2-hydroxy-4,-(2-hydroxyethoxy)-2-methylpropiophenone, oxyacetophenone, or 1 - benzothyridylcyclohexanol, or any two or combination of 'and b) diphenyl ketone, at least one of which has benzamidine ester' or at least one of which has a benzhydryl phenyl group or two or more A combination of a plurality of combinations) formed into a solution form. Preferred 2-hydroxy-2-methylpropiophenone and diphenyl ketone, 2-hydroxy-2-methylphthalic acid oxime of the component of the N-nitroso-N-phenylhydroxylamine aluminum salt Methyl benzoate, and 1-benzylidenecyclohexanol; more preferably 2-hydroxy-2-methylpropiophenone and diphenyl ketone. a) Pairs can be any, such as 0 · 1 ·· 9 9.9 to 9 9.9 : 0.1, which limits the liquid. For combinations involving 1-benzimidylcyclohexanol, the amount of 1-phenylhexanol is such that the composition is liquid and is typically in the range of about 80%; more preferably 1-benzylidenecyclohexanol It is a combination to about 70%; even more preferably from about 40% to about 60% of the cyclohexanol. For at least one acrylic acid having a benzoyl group and/or at least one having a benzhydryl phenyl group therein, when the ester or acrylate is a solid, the solid ester or acrylate is combined with b) by about 80% or more. less. a) a preferred ratio of b) to a range of about 80:20, more preferably a) a preferred ratio of b), no substituent P" is a hydrogen-containing ginseng (meth) , the α-diethyl phenyl ester of a greater variety, or a mixture thereof comprising a ratio of propiophenone to diphenyl ketone b) is from about 5 to about 30% of the formazan ring. The combination of the phenyl phenyl ester ester is usually a) | about 2 0 : 8 0 I from about 30:70 -13 to 200835700 to about 70:30. Still better a) to b) The ratio is from about 40:60 to about 60:40. The liquid polymerization inhibitor composition of the present invention has good solubility in common organic solvents and media, good stability, and can be used with high effective inhibition. Early maturing polymerization of various photohardenable formulations. Further, the components of these blends may be dispensed to provide little, if any, odor. The liquid polymerization inhibitor composition of the present invention contains at least about the total weight of the composition. 1. 1% by weight, generally at least about 1% by weight, preferably less than about 5% by weight, and more preferably at least about 6% by weight of ginseng Nitro-indole-phenylhydroxylamine) aluminum salt. The amount of cerium (non-nitroso-indolyl-phenylhydroxylamine) aluminum salt in an amount of up to about 8% by weight, 10% by weight and 12% by weight may be present in the present invention. The liquid composition of the invention. The composition of the blend is such that it does not exceed the room temperature of the cerium (nitroso-nitro-indolyl-hydroxyhydroxylamine) aluminum salt in the particular component used to form the liquid composition (eg 2 3 ° C) solubility limit. However, in the case where the appearance of the product is not an important factor, the composition may even be a concentrated turbid liquid • ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt preparation in this technique It is known and described, for example, in U.S. Patent No. 6,0,8,078. For example, the ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt can be reacted with an aluminum salt (such as aluminum sulfate). Salts are prepared with N-nitroso-N-phenylhydroxylamine ammonium salts, although other metal salts such as halide salts, phosphates, nitrates, carbonates, and organic acid salts can also be used. a polymerization inhibitor composition which uses a typical mixing apparatus such as a blending tank or a vessel equipped with a suitable agitation or agitation means, -14-200 835700 The ingredients are mixed together in any suitable manner.Additional ingredients may be included in the liquid polymerization inhibitor composition of the present invention, with the proviso that the ingredient does not actually detract from the beneficial properties of the composition in which it is used. Non-limiting examples of additional ingredients of the inventive blend include dyes, acrylate and/or methacrylate monomers and/or methacrylate oligomers, common organic solvents, oxidation inhibitors, viscosity modifiers, dips , photoinitiators, and tertiary amines. Non-limiting examples of such additional ingredients include acetone, isopropanol, acetonitrile, waxes, polymer powders, N,N-diethyl-4-aminobenzene (DEAB) , oxidized (2,4,6-trimethylbenzylidene) diphenylphosphine (TPO, Albemarle Corporation), 2-methyl-1-[4-(methylthio)phenyl]-2-? Oral propyl-1-one (Irgacure® 907, Ciba Chemical Specialties), phenyl phthalate (2,4,6-trimethylbenzoate) phosphine (Irgacure® 819, Ciba Chemical Specialties), liquid aliphatic amine Synergist (FIRSTCURE® AS-5 Amine, Albemarle Corporation), 4-(dimethylamino) Ethyl benzoate (ED AB), 2-ethylhexyl 4-(dimethylamino)benzoate (ODAB, Albemarle Corporation), N-methyl^-N,N-diethanolamine, ginseng (2, 4-di-t-butylphenyl)phosphite (ETHAPH0STM 3 6 8,A1 bem ar 1 e C orpor at i ο η), and 3- (3,5-di-t-butyl-4-hydroxyl) Phenyl) octadecyl propionate (ETHANOX® 376, Albemarle Corporation) 所得 When additional ingredients are used to form the polymerization inhibitor composition of the present invention, the resulting liquid polymerization inhibitor composition should contain at least about 1% by weight Nitrite (N-nitroso-N-phenylhydroxylamine) aluminum salt with a) 2-hydroxy-2-methylpropiophenone, 2-hydroxy-4'-(2-hydroxyethoxy)-2- Methylpropiophenone, a, oc-diethoxy-15-200835700 acetophenone, or 1-benzylidenecyclohexanol, or a combination of any two or more thereof; or b) diphenyl ketone , at least one ester having a benzhydrylphenyl group therein, or at least one acrylate having a benzhydrylphenyl group therein, or a combination of any two or more thereof; or c) both a) and b) a combination of conditions if a) is a 1-benzylidene ring Alcohols, derived from the at least one b) of the component is also present in the composition.
本發明之較佳聚合抑制劑組成物係由(例如至少約i 〇 重量%,而且較佳爲至少約20重量% )由参(N-亞硝基-N-苯基羥基胺)鋁鹽與a) 2-羥基-2-甲基苯丙酮、2-羥基-4,-(2 -羥基乙氧基)-2 -甲基苯丙酮、α,α -二乙氧基苯乙酮、 或1-苯甲醯基環己醇、或其任二或更多種之組合;或b)二 苯基酮、至少一種其中具有苯甲醯基苯基之酯、或至少一 種其中具有苯甲醯基苯基之丙烯酸酯、或其任二或更多種 之組合;或c)、a)與b)兩者組成之的成分…除了其爲或可 通常存在於成分本身之殘量雜質、或由接觸關於製備、運 輸及/或儲存成分或聚合抑制劑組成物本身之容器、攪拌輪 葉及/或軸、導管或管線、或類似裝備所得殘量雜質一而形 成,其條件爲如果a)爲1-苯甲醯基環己醇,則至少一種得 自b)之成分亦存在於該組成物中。 2)光可硬化調配物 本發明之液體聚合抑制劑組成物可包括作爲製備任何 光可硬化調配物之聚合抑制劑。例如使用聚合抑制劑組成 物形成之光可硬化調配物可另外含一或多種光可硬化單體 、一或多種光可硬化寡聚物或聚合物、或一或多種光引發 -16- 200835700 劑(自由基或陽離子性)。額外成分中,亦可在此 中之一或多種爲例如共引發劑(又稱爲增效劑)、 改劑、顏料、染料、光安定劑、自由基清除劑、與 進劑。組成物及及此物質之用法對熟悉此技藝者爲 ,敘述於文獻中,而且在市場上可得許多種在光可 配物中表現這些功能之產物。 使用本發明之液體聚合抑制劑組成物製造之光 調配物可藉由混合本發明之摻合物與一般用於形成 ® 硬化調配物之成分而形成。混合設備(如摻合槽或 適攪動或攪拌裝置之容器)可用於形成本發明之輻 化調配物。使用本發明之聚合抑制劑組成物製造之 化調配物一般含按調配物之總重量計爲約〇 . 〇 〇 5至I 量%範圍,而且較佳爲約0 · 1至約4重量%範圍之本 合物。 可用於形成光可硬化調配物之光可硬化單體、 及/或聚合物的數個非限制實例包括單體、寡聚、聚 ® 共聚形式之丙烯酸甲酯、甲基丙烯酸甲酯、丙烯酸 甲基丙烯酸乙酯、丙烯酸丁酯、甲基丙烯酸丁酯、 2-乙基己酯、甲基丙烯酸2-乙基己酯、丙烯酸月桂 基丙嫌酸月桂酯、丙橋酸環己酯、甲基丙燦酸環己 烯酸異莰酯、甲基丙烯酸異莰酯、丙烯酸羥基乙酯 丙烯酸羥基乙酯、丙烯酸二甲胺基丙酯、甲基丙嫌 胺基丙酯、丙烯酸二乙胺基丙酯、甲基丙烯酸二乙 酯等、及其任二或更多種之混合物。 調配物 流變修 黏附促 已知的 硬化調 可硬化 輻射可 裝有合 射可硬 光可硬 5 10重 發明摻 寡聚物 合、或 乙酯、 丙烯酸 酯、甲 酯、丙 、甲基 酸二甲 胺基丙 -17- 200835700 可用於此調配物之較佳光可硬化單體、寡聚物及/或聚 合物包括單體、寡聚、聚合、或共聚形式之三丙二醇二丙 烯酸酯、三羥甲基丙烷四丙烯酸酯、乙氧化三羥甲基丙烷 四丙烯酸酯、丙氧化新戊二醇二丙烯酸酯、己二醇二丙烯 酸酯等、及其任二或更多種之混合物。 一般爲了提供改良對特定基材之黏附性之目的,如果 需要則α,β-乙烯不飽和羧酸可結合丙烯酸酯及/或甲基丙烯 酸酯單體、寡聚物及/或聚合物使用。此酸之實例包括甲基 ® 丙烯酸、丙烯酸、伊康酸、順丁烯二酸、丙烯酸β -羧基乙 酯、甲基丙烯酸β-羧基乙酯等、及其任二或更多種之混合 物。 可用於此調配物之其他光可硬化單體、寡聚物及/或聚 合物包括單體、寡聚、聚合、或共聚形式之硫醇、乙儲醚 、乙烯酯、Ν-乙烯基化合物、不飽和聚酯、苯乙烯、二乙 烯基苯、丙烯腈、聚酯丙烯酸酯、聚胺基甲酸酯丙烯酸酯 、環氧基丙烯酸酯、聚醚丙烯酸酯、聚矽氧丙烯酸酯、氟 •丙烯酸酯、與胺丙烯酸酯。 接受光硬化之調配物一般含約〇 . 5至約8 5重量%範圍 之一或多種上述光可硬化單體、寡聚物或聚合物。較佳調 配物含約20至約75重量%範圍之一或多種此光可硬化物 質。其爲了一般調整黏度以適合使用之特定塗布方法而進 行這些範圍內之選擇。例如適合用於形成低黏度腹板塗料 之光可硬化調配物一般含按接受光硬化(輻射硬化)之全 部組成物的重量計爲約50至約70重量%範圍之一或多種 -18- 200835700 此單體、寡聚物或聚合物。 可用於可使用本發明之液體聚合抑制劑組成 光可硬化調配物的自由基光引發劑具有兩種一般 I型’進行光分離而產生自由基者,及第II型, 程製造引發自由基者。第I型光引發劑經單分子 自由基。其實例包括芳族羰基化合物,如安息香 醯縮酮與苯乙酮之衍生物。第II型(摘取型)光 般爲芳族酮,如9 -氧硫_喔與二苯基酮衍生物。 統中,其必須存在共引發劑以製造引發自由基。 發劑可包括胺、醇、硫醇、或醚。製造自由基之 共引發劑經氫摘取或電子轉移機構。 可用於輻射可硬化調配物之光引發劑的非限 栝第I型(單分子碎片型)引發劑,如α_二酮化 單縮酮衍生物(例如二乙醯基、二苯乙醯、苄基 基縮酮衍生物);醯偶因(例如安息香、4-羥基 ^ 四甲基己-3-酮(Pivaloin)等);醯偶因醚(例如安 、安息香乙醚、安息香丙醚等)、醯基氧化膦、及 之第I型引發劑,包括任二或更多種此引發劑之 類似地,其可使用第Η型(摘取型)引發劑。 型引發劑之非限制實例包括_酮、9_氧硫_喔、 、安息香、二苯基酮、4,4,-貳(ν,Ν,-二甲胺基) 、多核醌(例如9,1 0 -蒽醌、9,1 〇 -菲醌、2 -乙基 1,4-萘醌)等、及其任二或更多種之混合物。較 型引發劑包括縮酮,如安息香二甲基縮酮。較佳 物形成之 型式:第 經摘取過 碎片製造 、二苯乙 引發劑一 在這些系 這些共引 方法爲依 制實例包 合物或其 、或二甲 ;-2,2,5,5 - 息香甲醚 其他類似 混合物。 合適第II 2_氯咄酮 二苯基酮 蒽醌、與 佳之第I 之第II型 -19- 200835700 引發劑包括氫醌,如苯醌與2 -乙基蒽醌。亦可使用第i型 與第II型引發劑之混合物。引發劑或引發劑之混合物一般 以每1 〇 〇重量份之待光硬化單體、寡聚物或聚合物爲約 0 · 0 1至約1 0重量份,較佳爲約0 · 〇 5至約5重量份之量加 入。 可用於調配物之各種共引發劑中,其一般有利地使用 三級胺。可用於調配物之胺引發劑的數個非限制實例包括 >1-[3-(二甲胺基)丙基]->1,:^’,1^’-三甲基-1,3-丙二胺 _ (Polycat 77; Air Products,Inc·)、2,2’-氧基戴[N,N-二甲基 乙胺](DABCO BL-19; Air Products,Inc·)、N,N -二甲基-4-嗎啉乙胺(DABCO XDM; Air Products,Inc.);甲基二乙醇 胺;丙烯酸酯胺;4-(二甲胺基)苯甲酸2-乙基己酯(〇DAB) ;4-(二甲胺基)苯甲酸乙酯(EDAB);嗎啉衍生物;及一 或多種分子中各具有總共1 (V至約3 6個碳原子,而且其中 至少一個烷基具有至少8個碳原子之鏈長的三烷基胺,例 如(A)—或多種分子中各具有總共10至約24個碳原子,而 # 且其中烷基之二爲甲基或乙基或其一(更佳爲均爲甲基) ,其餘院基含至少8個碳原子(而且更佳爲含8至約22個 碳原子範圍之一級烷基)的三烷基胺,或(B)—或多種分子 中各具有總共17至約38個碳原子,而且其中烷基之〜爲 甲基或乙基(較佳爲甲基),另外兩個烷基爲相同或不同且 各爲一級烷基的三烷基胺。十二碳基二甲胺、十四碳基二 甲胺、十六碳基二甲胺、十八碳基二甲胺、二癸基甲胺、 與十二碳基甲胺爲(A)或(B)之三級胺的例證。其可使用二 -20- 200835700 或更多種三級胺共引發劑之混合物。胺量一般爲調配物總 重量之約〇 · 5至約4 0重量%的範圍。 可用於形成調配物之流變修改劑的非限制實例包括如 有機聚矽氧化合物、有機氟化合物、聚醚、及有機離子性 化合物之材料。一般而言,流變修改劑係以調配物之約〇 . 〇 1 至約5重量%之量使用。 可使用顏料及染料且經常較佳地用於光硬化調配物。 用於調配物之顏料的實例及典型量包括酞青藍(約5至約 • 20重量% )、二氧化鈦(約1 〇至約3 〇重量% )、或其他用於 此技藝之有機或無機顏料。視情況地,其可使用如苯胺黑 或亞甲基藍之染料增強顏色或色調(例如約1至約5重量 % ) 〇 光安定劑爲另一型可用於其中使用本發明液體聚合抑 制劑組成物之光可硬化調配物的添加劑。此光安定劑之非 限制實例包括2-羥基二苯基酮,如2,2’-二羥基-4,4’-二甲 氧基二苯基酮,2-(2-羥基苯基)苯并三唑,如2-(2’-羥 基苯基)苯并三唑,立體位阻胺,如貳(2,2,6,6-四甲基-4-哌啶基)癸二酸酯或貳(2,2,6,6-四甲基-4-哌啶基)琥珀酸 酯,草醯胺,如4,4’-二辛基氧基苯醯胺,丙烯酸酯,如α-氰基-β,β-二苯基丙烯酸乙酯或α-羰甲氧基桂皮酸甲酯、及 鎳錯合物,如2,2’-硫貳(1,1,3,3-四甲基丁基)酚之鎳錯 合物。一般而言,使用量依使用之特定型式光安定劑爲約 0.02至約5重量%之範圍。 又一型可用於形成輻射可硬化組成物之添加劑爲一或 -21- 200835700 多種自由基清除劑。此用途之合適自由基清除劑的非限制 實例包括氫醌、氫醌甲醚、對第三丁基兒茶酚、醌型化合 物(如苯醌與經烷基取代苯醌)、及其他此技藝已知之自由 基清除劑。一般而言,這些成分係使用以組成物之約1 〇 〇 p p m至約2重量%範圍之量。 黏附促進劑組成再一型可用於形成其中使用本發明液 體聚合抑制劑組成物之光可硬化組成物的添加劑成分。此 成分一般爲矽烷衍生物,如γ-胺基丙基三乙氧基矽烷(DOW A-11 00)及等價經取代矽烷產物;酸官能基取代樹脂;有 或無丙烯酸或甲基丙烯酸不飽和之寡聚物或單體,如磷酸 、順丁烯二酸酐或酞酸酐之部分酯;及丙烯酸/甲基丙烯酸 之二聚物與三聚物。如果使用黏附促進劑,則較佳型式爲 α,β-乙烯不飽和羧酸以外者。如果且在使用時,其濃度係 藉黏附測試實驗地決定。然而通常此量經常爲組成物之總 重量的約0.5至約20重量%之範圍,而且在更佳之情形爲 約2至約1 0重量%之範圍。 在進行光硬化時可使用同調或非同調輻射。其可使用 此輻射之各種來源,如離子氣體雷射(例如氬離子雷射、 氪雷射、氯:鎘雷射等)、固態雷射(例如倍頻Nd:YAG雷 射)、半導體二極體雷射、電弧燈(例如中壓汞燈、氙燈或 碳弧燈)等輻射來源。可提供紫外線與可見光波長輻射( 波長一般爲200-700奈米之範圍)之曝光來源亦可用於進 行先硬化。較佳波長爲對應所使用引發劑之光譜敏感度者 。較佳之輻射來源爲使用汞、氬、鎵、或鐵鹽之蒸氣且利 -22- 200835700 用磁性、微波或電子整流器的氣體放電燈;此燈常 录燈、或Fusion Systems製造之燈(即〇、Η與V 4 曝光時間可依輻射來源及使用之光引發劑而定 高速應用,如形成以高線性速度通過之薄塗層或紙 其希望爲約〇 . 〇 〇 5至約〇 · 〇 1 5秒之時間。在其中欲聚 物爲靜止或在輸送帶上緩慢地移動之輻射硬化(光 操作中,其可使用較長之曝光時間(例如約0 · 2至 秒之範圍)。 • 其有各種進行光硬化操作之已知方式。例如可 硬化調配物光聚合成爲薄塗層或穿越腹板。或者可 可硬化調配物在基材上光聚合或光硬化成爲塗層或 。另一種變化爲將輻射可硬化調配物在模具中光聚 物品或形狀。在這些及其他模式之操作中,暴露於 進行硬化或光聚合可爲連續或間斷。 各種輻射硬化物品及形狀可藉由輻射硬化使用 之聚合抑制劑形成之光可聚合組成物而製造。因此 ^ 化(光聚合)最終產物可爲基材上之印刷物質,如 板或塑膠膜等;製造物品,如握柄、把手、墨水瓶 托盤、尺規等;及基材上之塗層或層合物,如合板 片、聚合物複合片等。如上所示,其中塗層厚度爲 至約10 mils之薄塗覆紙及塗覆硬紙板或薄紙板料 光可硬化組成物製造之所需物品。 以下實例描述本發明之實務及一些優點。實例 限制且不應視爲限制本發明之一般範圍。 爲中壓 登)° 。對於 腹板, 合混合 聚合) 約 0.4 將光可 將輻射 層合物 合成爲 輻射以 本發明 輻射硬 紙、紙 架、小 、金屬 約 0.0 2 組成由 不意圖 -23- 200835700 實例1 藉由製備含10重量%之参(N-亞硝基-N -苯基經基胺 )銘鹽(FIRSTCURE® NPAL 聚合抑制劑;Albemarle Corporation)、及90重量%之2-羥基·2-甲基苯丙酮與二苯 基酮之混合物的液體混合物’而形成本發明之聚合抑制劑 組成物。2-羥基-2-甲基苯丙酮與二苯基酮爲40:60重量比 例。此液體組成物在5 0 °F (約1 0 °C )安定4曰。 實例2 # 藉由製備含8重量%之参(N-亞硝基-N-苯基羥基胺) 鋁鹽(FIRSTCURE® NPAL 聚合抑制劑;Albemarle Corporation)、及92重量%之1-苯甲醯基環S醇與二苯基 酮之混合物的液體混合物,而形成本發明之聚合抑制劑組 成物。b苯甲醯基環己醇與二苯基酮爲40:60重量比例。 此液體組成物室溫安定。 實例3 藉由製備含7.5重量%之参(N-亞硝基-N-苯基羥基胺 • )鋁鹽(FIRSTCURE® NPAL 聚合抑制劑;Albemarle Corporation )、及92.5重量%之2-羥基-2-甲基苯丙酮的液 體混合物,而形成本發明之聚合抑制劑組成物。此液體組 成物室溫安定。 實例4 藉由製備含7重量%之参(N-亞硝基-N-苯基羥基胺) 鋁鹽(FIRSTCURE® NPAL 聚合抑制劑;Albemarle Corporation)、及93重量%之2-羥基-2-甲基苯丙酮與鄰苯 -24- 200835700 甲醯基苯甲酸甲酯之混合物的液體混合物,而形成本發明 之聚合抑制劑組成物。2-羥基-2-甲基苯丙酮與鄰苯甲醯基 苯甲酸甲酯爲60:40重量比例。 實例5 藉由製備含12重量%之参(N-亞硝基-N-苯基羥基胺 )鋁鹽(FIRSTCURE⑧ NPAL 聚合抑制劑;Albemarle Corporation)、及88重量%之2 -經基-2-甲基苯丙調與二苯 基酮之混合物的液體混合物,而形成本發明之聚合抑制劑 # 組成物。2-羥基-2-甲基苯丙酮與二苯基酮爲50:50重量比 例。 應了解,在說明書或其申請專利範圍任意處之化學名 稱或化學式所指成分,不論指單數或複數,均以其在接觸 以化學名稱或化學型式所指之其他物質(例如其他反應物 、溶劑、稀釋劑等)前存在而驗證。在所得混合物或溶液 中發生之化學變化、轉變及/或反應(若有)均無關,因爲 此變化、轉變及/或反應爲在依照本揭示之條件下使指定反 β 應物及/或成分在一起之自然結果。因此反應物及其他材料 係驗證爲關於實行所需化學反應或形成用於進行所需反應 之混合物而在一起之組分。又即使以下申請專利範圍可能 以現在式(「包括」、「爲」等)指物質、成分及/或組分, 此指稱爲其恰在依照本揭示最先接觸、摻合或混合一或多 種其他物質或組分前存在之物質或組分。物質或成分可能 在此接觸、摻合或混合操作期間經化學反應或轉變失去其 原始身分因此對本揭示及其申請專利範圍之正確了解及熟 -25- 200835700 知完全不重要。 本說明書之任何部分指稱之各專利或公告在此全部倂 入本揭示作爲參考,如同完全敘述。 除了另有明確地表示,在此使用之名詞”a”或”an”不意 圖限制,而且不應視爲限制爲名詞所指之單一元素。而是 在此使用之名詞”a”或”an”意圖涵蓋一或多種此元素,除了 另有明確地表示。 本發明實務上可大幅變動。因此以上之說明不意圖限 ® 制,而且不應視爲將本發明限於以上提出之特定實例。而 是意圖涵蓋如以下申請專利範圍所述。 【圖式簡單說明】Preferred polymerization inhibitor compositions of the present invention are comprised of (for example at least about 9% by weight, and preferably at least about 20% by weight) of ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt and a) 2-hydroxy-2-methylpropiophenone, 2-hydroxy-4,-(2-hydroxyethoxy)-2-methylpropiophenone, α,α-diethoxyacetophenone, or 1 - benzhydrylcyclohexanol, or a combination of any two or more thereof; or b) diphenyl ketone, at least one ester having a benzhydryl phenyl group therein, or at least one having a benzamidine group therein a phenyl acrylate, or a combination of any two or more thereof; or a component consisting of c), a) and b), except that it is or may be present in the residue itself of the component itself, or Contacting a residual amount of impurities obtained from the container for preparing, transporting and/or storing the component or the polymerization inhibitor composition itself, the agitating blades and/or the shaft, the conduit or the pipeline, or the like, provided that a) is 1-Benzyldecylcyclohexanol, at least one component derived from b) is also present in the composition. 2) Photohardenable formulation The liquid polymerization inhibitor composition of the present invention may comprise a polymerization inhibitor as a preparation for any photohardenable formulation. For example, a photohardenable formulation formed using a polymerization inhibitor composition may additionally comprise one or more photohardenable monomers, one or more photohardenable oligomers or polymers, or one or more photoinitiated-16-200835700 agents (free radical or cationic). Among the additional ingredients, one or more of them may be, for example, a co-initiator (also known as a synergist), a modifier, a pigment, a dye, a photostabilizer, a radical scavenger, and an admixture. The use of the compositions and their materials is well known to those skilled in the art and is described in the literature as well as many commercially available products which exhibit these functions in photorepensibles. The photocatalyst produced using the liquid polymerization inhibitor composition of the present invention can be formed by mixing the blend of the present invention with a component generally used to form a ® hardening formulation. Mixing equipment, such as blending tanks or vessels suitable for agitation or agitation, can be used to form the radiation formulations of the present invention. The formulation prepared using the polymerization inhibitor composition of the present invention generally comprises a range of from about 〇5 to about 1% by weight based on the total weight of the formulation, and preferably from about 0. 1 to about 4% by weight. The compound. Several non-limiting examples of photohardenable monomers, and/or polymers that can be used to form photohardenable formulations include monomeric, oligomeric, poly(meth) methacrylate, methyl methacrylate, acrylic Ethyl acrylate, butyl acrylate, butyl methacrylate, 2-ethylhexyl acrylate, 2-ethylhexyl methacrylate, lauryl acrylate, lauryl acrylate, cyclohexyl acrylate, methyl Isodecyl cyclohexenoate, isodecyl methacrylate, hydroxyethyl acrylate hydroxyethyl acrylate, dimethylaminopropyl acrylate, methyl propyl propyl propyl ester, diethyl propyl acrylate An ester, diethyl methacrylate or the like, and a mixture of two or more thereof. Formulation of logistics modification adhesion promotes known hardening and hardenable radiation can be equipped with condensing hard light hardening 5 10 invention invention oligopolymer, or ethyl ester, acrylate, methyl ester, propyl, methyl acid Methylaminopropane-17-200835700 Preferred photohardenable monomers, oligomers and/or polymers useful in this formulation include monomeric, oligomeric, polymeric, or copolymeric forms of tripropylene glycol diacrylate, three Hydroxymethylpropane tetraacrylate, ethoxylated trimethylolpropane tetraacrylate, propoxy neopentyl glycol diacrylate, hexanediol diacrylate, and the like, and a mixture of two or more thereof. In general, in order to provide improved adhesion to a particular substrate, the α,β-ethylenically unsaturated carboxylic acid may be used in combination with acrylate and/or methacrylate monomers, oligomers and/or polymers, if desired. Examples of the acid include methyl ® acrylic acid, acrylic acid, itaconic acid, maleic acid, β-carboxyethyl acrylate, β-carboxyethyl methacrylate, and the like, and a mixture of any two or more thereof. Other photohardenable monomers, oligomers and/or polymers useful in the formulations include thiols, ethyl ethers, vinyl esters, oxime-vinyl compounds, in monomeric, oligomeric, polymeric, or copolymeric forms, Unsaturated polyester, styrene, divinylbenzene, acrylonitrile, polyester acrylate, polyurethane acrylate, epoxy acrylate, polyether acrylate, polyoxy acrylate, fluoroacetic acid Ester, and amine acrylate. The photohardenable formulation typically comprises from about 5 to about 85 percent by weight of one or more of the above photohardenable monomers, oligomers or polymers. Preferred formulations contain from about 20 to about 75% by weight of one or more of such photohardenable materials. It is selected within these ranges in order to generally adjust the viscosity to suit the particular coating method used. For example, photohardenable formulations suitable for use in forming low viscosity web coatings generally comprise one or more of the range from about 50 to about 70 weight percent based on the weight of all of the compositions that receive photohardening (radiation hardening) -18-200835700 This monomer, oligomer or polymer. The free radical photoinitiator which can be used to form a photohardenable formulation using the liquid polymerization inhibitor of the present invention has two general types I, which are photo-separated to generate free radicals, and type II, which produces free radicals. . The Type I photoinitiator passes through a single molecule of free radicals. Examples thereof include aromatic carbonyl compounds such as derivatives of benzoin ketal and acetophenone. Type II (extracted) is generally an aromatic ketone such as a 9-oxo-sulfonium- and diphenyl ketone derivative. In the system, a co-initiator must be present to make the initiation of free radicals. Hair sprays can include amines, alcohols, thiols, or ethers. The co-initiator that produces free radicals is subjected to a hydrogen extraction or electron transfer mechanism. A non-limiting type I (single molecule fragment) initiator that can be used as a photoinitiator for radiation hardenable formulations, such as alpha-diketone monoketal derivatives (eg, diethylidene, diphenylacetamone, Benzyl ketal derivatives); oxime (such as benzoin, 4-hydroxy^tetramethylhex-3-one (Pivaloin), etc.); oxime ether (such as benzoic acid, benzoin ethyl ether, benzoin, etc.) The fluorenylphosphine oxide, and the Type I initiator, including any two or more of such initiators, may employ a Di-type (extracted) initiator. Non-limiting examples of type initiators include ketone, 9-oxo-sulfonium, benzoin, diphenyl ketone, 4,4,-fluorene (ν, fluorene, -dimethylamino), polynuclear hydrazine (eg 9, 1 0 -蒽醌, 9,1 〇-phenanthrenequinone, 2-ethyl 1,4-naphthoquinone), and the like, and a mixture of two or more thereof. Suitable initiators include ketals such as benzoin dimethyl ketal. The preferred form of formation: the first extraction of the fragment, the diphenylethyl initiator - in these systems, the co-introduction method is based on the example inclusion compound or its dimethyl; -2, 2, 5, 5 - Other similar mixtures of fragrant methyl ether. Suitable II 2 -chloroindolone Diphenyl ketone oxime, and preferred I type II -19- 200835700 initiators include hydroquinones such as benzoquinone and 2-ethyl hydrazine. Mixtures of Type I and Type II initiators can also be used. The initiator or the mixture of initiators is generally from about 0. 01 to about 10 parts by weight, preferably from about 0. to about 5 parts by weight, per 1 part by weight of the monomer, oligomer or polymer to be photohardened. It is added in an amount of about 5 parts by weight. Among the various co-initiators which can be used in the formulation, it is generally advantageous to use tertiary amines. Several non-limiting examples of amine initiators that can be used in the formulation include >1-[3-(dimethylamino)propyl]->1,:^', 1^'-trimethyl-1, 3-propanediamine _ (Polycat 77; Air Products, Inc.), 2,2'-oxydene [N,N-dimethylethylamine] (DABCO BL-19; Air Products, Inc.), N , N-dimethyl-4-morpholine ethylamine (DABCO XDM; Air Products, Inc.); methyl diethanolamine; acrylate amine; 4-(dimethylamino)benzoic acid 2-ethylhexyl ester ( 〇DAB); 4-(dimethylamino)benzoic acid ethyl ester (EDAB); morpholine derivative; and one or more molecules each having a total of 1 (V to about 36 carbon atoms, and at least one of which is at least one alkane a trialkylamine having a chain length of at least 8 carbon atoms, such as (A) - or a plurality of molecules each having a total of 10 to about 24 carbon atoms, and # and wherein the alkyl group is a methyl or ethyl group Or one (more preferably all methyl), the remaining pendant group containing at least 8 carbon atoms (and more preferably a linear alkyl group having from 8 to about 22 carbon atoms), or (B) ) or a plurality of molecules each having a total of 17 to about 38 carbon atoms, and wherein the alkane Is a methyl or ethyl group (preferably a methyl group), and the other two alkyl groups are the same or different trialkylamines each of which is a primary alkyl group. Dodecyl dimethylamine, tetradecyldiyl An example of methylamine, hexadecyldimethylamine, octadecyldimethylamine, dimercaptomethylamine, and dodecylmethylamine being a tertiary amine of (A) or (B). Mixture of di-20-200835700 or more tertiary amine co-initiators. The amount of amine is generally in the range of from about 〇·5 to about 40% by weight based on the total weight of the formulation. Rheology modifiers which can be used to form formulations Non-limiting examples include materials such as organopolyoxo compounds, organofluorine compounds, polyethers, and organic ionic compounds. In general, rheology modifiers are formulated to about 〇1 to about 5% by weight. Amounts can be used. Pigments and dyes can be used and are often preferred for photohardening formulations. Examples and typical amounts of pigments for formulations include indigo blue (about 5 to about 20% by weight), titanium dioxide (about 1 〇 to about 3 〇% by weight), or other organic or inorganic pigments used in this art. Depending on the situation It may use a dye such as aniline black or methylene blue to enhance color or hue (for example, from about 1 to about 5 wt%). The tanning stabilizer is another type which can be used for the photohardenable formulation in which the liquid polymerization inhibitor composition of the present invention is used. Additives. Non-limiting examples of such light stabilizers include 2-hydroxydiphenyl ketones such as 2,2'-dihydroxy-4,4'-dimethoxydiphenyl ketone, 2-(2-hydroxybenzene). Benzotriazole, such as 2-(2'-hydroxyphenyl)benzotriazole, a sterically hindered amine such as anthracene (2,2,6,6-tetramethyl-4-piperidinyl)anthracene Diester or hydrazine (2,2,6,6-tetramethyl-4-piperidinyl) succinate, physic amine, such as 4,4'-dioctyloxybenzophenone, acrylate, Such as α-cyano-β, β-diphenylacrylate or methyl α-carbonylmethoxycinnamate, and nickel complexes such as 2,2′-thiopurine (1,1,3,3 a nickel complex of tetramethylbutyl phenol. Generally, the amount employed will range from about 0.02 to about 5 weight percent, depending on the particular type of light stabilizer used. Another type of additive that can be used to form the radiation hardenable composition is one or -21 - 200835700 various free radical scavengers. Non-limiting examples of suitable free radical scavengers for this use include hydroquinone, hydroquinone methyl ether, p-tert-butylcatechol, anthraquinone compounds (such as benzoquinone and alkyl-substituted benzoquinone), and other such techniques Known free radical scavengers. Generally, these ingredients are used in amounts ranging from about 1 〇 〇 p p m to about 2% by weight of the composition. The adhesion promoter composition can be used to form an additive component in which the photohardenable composition of the liquid polymerization inhibitor composition of the present invention is used. This component is generally a decane derivative such as γ-aminopropyltriethoxydecane (DOW A-11 00) and an equivalent substituted decane product; an acid functional group-substituted resin; with or without acrylic acid or methacrylic acid a saturated oligomer or monomer, such as a partial ester of phosphoric acid, maleic anhydride or phthalic anhydride; and a dimer and trimer of acrylic acid/methacrylic acid. If an adhesion promoter is used, the preferred form is other than α,β-ethylenically unsaturated carboxylic acid. If and when used, the concentration is determined experimentally by the adhesion test. Usually, however, this amount will often range from about 0.5 to about 20% by weight of the total weight of the composition, and more preferably from about 2 to about 10% by weight. Coherent or non-coherent radiation can be used for photohardening. It can use various sources of this radiation, such as ionic gas lasers (such as argon ion laser, krypton laser, chlorine: cadmium laser, etc.), solid state laser (such as frequency doubling Nd: YAG laser), semiconductor diode Radiation sources such as body lasers, arc lamps (eg medium pressure mercury lamps, xenon lamps or carbon arc lamps). Exposure sources that provide ultraviolet and visible wavelength radiation (typically in the range of 200-700 nm) can also be used for prior hardening. Preferred wavelengths are those corresponding to the spectral sensitivity of the initiator used. Preferred sources of radiation are vapors using mercury, argon, gallium, or iron salts and Li--22-200835700 gas discharge lamps using magnetic, microwave or electronic rectifiers; this lamp is often recorded, or a lamp manufactured by Fusion Systems (ie, 〇 , Η and V 4 exposure time can be applied at high speed depending on the source of radiation and the photoinitiator used, such as forming a thin coating or paper that passes at a high linear velocity. It is desirable to be about 〇. 〇〇5 to about 〇· 〇1 5 seconds. Radiation hardening in which the polymer is stationary or moving slowly on the conveyor belt (light operation can use a longer exposure time (for example, in the range of about 0.2 to 2 seconds). There are various known ways of performing photohardening operations, such as photopolymerization of a hardenable formulation into a thin coating or through a web. Alternatively, a cocoa hardening formulation can be photopolymerized or photohardened onto a substrate to form a coating or coating. The radiation hardenable formulation is condensed into the article or shape in the mold. In these and other modes of operation, exposure to hardening or photopolymerization can be continuous or intermittent. Various radiation hardening articles and shapes can be The radiation hardening is produced by using a photopolymerizable composition formed by a polymerization inhibitor. Therefore, the final product (photopolymerization) can be a printed matter on a substrate, such as a plate or a plastic film; and an article such as a handle or a handle , ink bottle trays, rulers, etc.; and coatings or laminates on the substrate, such as plywood sheets, polymer composite sheets, etc. As shown above, thin coated paper having a coating thickness of up to about 10 mils and The following examples illustrate the practice of the invention and some of its advantages. The examples are intended to be limiting and should not be construed as limiting the general scope of the invention. For the web, mixed polymerization) about 0.4 light can be used to synthesize the radiation laminate into radiation. The radiation hard paper, paper holder, small, metal of the present invention is composed of about 0.0 2 by not intending -23-200835700 Example 1 Preparation of 10% by weight of ginseng (N-nitroso-N-phenylcarbylamine) salt (FIRSTCURE® NPAL polymerization inhibitor; Albemarle Corporation), and 90% by weight of 2-hydroxy-2-methylbenzene Acetone and diphenyl ketone Compound mixture liquid 'form a polymerization inhibitor composition of the present invention. The ratio of 2-hydroxy-2-methylpropiophenone to diphenyl ketone was 40:60 by weight. This liquid composition is stabilized at 50 °F (about 10 ° C). Example 2 # By preparing 8% by weight of ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt (FIRSTCURE® NPAL polymerization inhibitor; Albemarle Corporation), and 92% by weight of 1-benzamide A liquid mixture of a mixture of a base S alcohol and a diphenyl ketone to form a polymerization inhibitor composition of the present invention. b benzhydrylcyclohexanol and diphenyl ketone are 40:60 by weight. This liquid composition is stable at room temperature. Example 3 Preparation of 7.5% by weight of ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt (FIRSTCURE® NPAL polymerization inhibitor; Albemarle Corporation), and 92.5% by weight of 2-hydroxy-2 a liquid mixture of methyl phenylacetone to form a polymerization inhibitor composition of the present invention. This liquid composition is stable at room temperature. Example 4 By preparing 7% by weight of ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt (FIRSTCURE® NPAL polymerization inhibitor; Albemarle Corporation), and 93% by weight of 2-hydroxy-2- A liquid mixture of a mixture of methyl propiophenone and o-phenyl-24-200835700 methylmercaptobenzoic acid to form a polymerization inhibitor composition of the present invention. 2-Hydroxy-2-methylpropiophenone and o-benzimidylbenzoic acid methyl ester were in a 60:40 weight ratio. Example 5 Preparation of 12% by weight of ginseng (N-nitroso-N-phenylhydroxylamine) aluminum salt (FIRSTCURE 8 NPAL polymerization inhibitor; Albemarle Corporation), and 88% by weight of 2-amino group-2- A liquid mixture of a mixture of methotrexate and diphenyl ketone forms the composition of the polymerization inhibitor # of the present invention. The ratio of 2-hydroxy-2-methylpropiophenone to diphenyl ketone was 50:50 by weight. It should be understood that the chemical name or chemical formula referred to anywhere in the specification or its patent application, whether singular or plural, refers to other substances referred to by chemical name or chemical type (such as other reactants, solvents). , thinner, etc.) exist before verification. The chemical changes, transitions, and/or reactions (if any) occurring in the resulting mixture or solution are irrelevant because the changes, transformations, and/or reactions are such that the specified anti-beta and/or components are selected under the conditions of the present disclosure. The natural result together. Thus, the reactants and other materials are verified as components that are used to carry out the desired chemical reaction or to form a mixture for carrying out the desired reaction. Furthermore, even though the scope of the following claims may refer to substances, ingredients and/or components in the present form ("including", "as", etc.), it is meant to refer to one or more of the first contact, blending or mixing in accordance with the present disclosure. A substance or component that is present before other substances or components. The substance or ingredient may lose its original identity by chemical reaction or transformation during this contact, blending or mixing operation and is therefore completely unimportant to the knowledge and understanding of the disclosure and the scope of the patent application. Each of the patents or publications referred to in any part of this specification is hereby incorporated by reference in its entirety in its entirety. The term "a" or "an" as used herein is not intended to be limiting, and should not be construed as limited to a single element. The term "a" or "an" as used herein is intended to encompass one or more of this element unless the The practice of the invention can vary widely. Therefore, the above description is not intended to be limiting, and should not be construed as limiting the invention to the specific examples set forth above. It is intended to cover the scope of the patent application below. [Simple description of the map]
dnSL 通0 【元件符號說明】 4mi 無0dnSL pass 0 [component symbol description] 4mi no 0
-26--26-
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86511906P | 2006-11-09 | 2006-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200835700A true TW200835700A (en) | 2008-09-01 |
Family
ID=37983548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW96141963A TW200835700A (en) | 2006-11-09 | 2007-11-07 | Polymerization inhibitor compositions, their preparation, and their use |
Country Status (2)
Country | Link |
---|---|
TW (1) | TW200835700A (en) |
WO (1) | WO2008060844A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1522444B2 (en) * | 1967-03-10 | 1977-07-07 | Basf Ag, 6700 Ludwigshafen | POLYMERIZATION INHIBITOR CONTAINING LIGHT-NETWORKABLE MIXTURE |
DE3380028D1 (en) * | 1982-10-01 | 1989-07-13 | Ciba Geigy Ag | Propiophenone derivatives as photoinitiators in the photopolymerization |
US4563438A (en) * | 1983-05-06 | 1986-01-07 | Ciba Geigy Corporation | Liquid mixture of photoinitiators |
TW407145B (en) * | 1995-10-02 | 2000-10-01 | Idemitsu Pertrochemical Co Ltd | Process for inhibiting polymerization of a vinyl compound |
US6018078A (en) * | 1999-06-23 | 2000-01-25 | First Chemical Corporation | Stabilized N-nitrosohydroxylamines |
JP2003119205A (en) * | 2001-10-12 | 2003-04-23 | Asahi Denka Kogyo Kk | Polymerization inhibitor composition |
-
2007
- 2007-10-29 WO PCT/US2007/082835 patent/WO2008060844A1/en active Application Filing
- 2007-11-07 TW TW96141963A patent/TW200835700A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008060844A1 (en) | 2008-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2550250B1 (en) | Amine synergists and their use in radiation curing | |
TW200424766A (en) | Photocurable compositions | |
JP6391713B2 (en) | Water dispersible support material for 3D printing | |
Segurola et al. | Photoyellowing and discolouration of UV cured acrylated clear coatings systems: influence of photoinitiator type | |
JP2012051927A (en) | White solid photoinitiator in powdery form and production of the same | |
TWI791844B (en) | Articles prepared using curable compositions based on polymerizable ionic species | |
EP3737562A1 (en) | Group iv metal chelates and their use in radiation curable ink and coating compositions | |
WO2014094658A1 (en) | Alkylphenyl derivatives and application thereof as photoinitiator | |
US20070066842A1 (en) | Polymerization Inhibitor Compositions, Their Preparation, and Their Use | |
CN101434543A (en) | Polyfunctional benzophenone derivates and uses as photoinitiators thereof | |
TW200835700A (en) | Polymerization inhibitor compositions, their preparation, and their use | |
JP6766067B2 (en) | Functionalized photoinitiator | |
JP2018002817A (en) | Photoradical polymerizable composition and method of curing the same | |
EP4244281B1 (en) | Photoinitiator resins with dibenzoylmethane substructure | |
BR112020004184A2 (en) | energy-curable low migration inks | |
US20060293404A1 (en) | New class of amine coinitiators in photoinitiated polymerizations | |
JP2003160626A (en) | Photosetting resin | |
TW202235414A (en) | Type-ii photoinitiators | |
KR20240004994A (en) | Radiation-curable compositions for creating support sub-structures for 3D photopolymer spraying | |
TW201829481A (en) | Diallyl phthalate resin modified by thiol compound, photo-curable resin composition including said resin, and use thereof | |
JPH0554842B2 (en) |